Please enable JavaScript to view the site.

Services
What's New
Audit & Assurance

IASPlus

Assurance Services

Complex Accounting Assurance

Accounting Operations Assurance

Media & Advertising Assurance

Disruptive Events Assurance

Consulting

Strategy, Analytics and M&A

Customer and Marketing

Core Business Operations

Human Capital

Enterprise Technology & Performance

Risk Advisory

Strategic & Reputation Risk

Regulatory Risk

Financial Risk

Operational Risk

Cyber Risk
Financial Advisory

Mergers & Acquisitions

Restructuring Services

Deloitte Forensic

Legal

Deloitte Legal around the world

Dbriefs Legal

Deloitte Legal services

Tax

Global Business Tax

Global Employer Services

Global Tax Reset

Tax Automation and AI
Industries
What's New
Consumer

Automotive

Consumer Products

Retail, Wholesale & Distribution

Transportation, Hospitality & Services

Energy, Resources & Industrials

Industrial Products & Construction

Mining & Metals

Oil, Gas & Chemicals

Power & Utilities

The Future of Energy

Financial Services

Banking & Capital Markets

Insurance

Investment Management

Real Estate
Government & Public Services

Civil Government

Defense, Security & Justice

Health & Social Care

International Donor Organizations

Transport

Life Sciences & Health Care

Health Care

Life Sciences

Technology, Media & Telecommunications

Technology

Telecommunications, Media & Entertainment
Insights
What's New
By topic

AI & cognitive technologies

Analytics

Blockchain

Digital transformation

Diversity & inclusion

Economics

Human capital

Innovation

Leadership

Private companies

Risk management

Strategy

By sector

Automotive

Consumer products & retail

Financial services

Government & public services

Health care

Industrial products

Life sciences

Oil, gas & chemicals

Power & utilities

Technology

Telecom, media & entertainment

Transportation & hospitality

Spotlight

Daily Executive Briefing

Deloitte Review

Economic weekly update

Future of mobility

Future of work

Industry 4.0

Internet of Things

Smart cities
Careers
What's New
- Millennial Survey 2019
  Optimism and trust reach troubling low levels
- Alumni profiles
  Inspiring leaders
Job search

Experienced hires

Students

Life at Deloitte

Alumni

GLOBAL-EN Location: GLOBAL-English
Contact us

GLOBAL-EN Location: GLOBAL-English
Contact us

Life Sciences & Health Care

Rapid transformation in life sciences and health care industry requires firms to strike a balance between patient’s demands, market potential, and policy compliance, while continuing innovation. We offer holistic solutions that help clients remain competitive in this constantly evolving market.

Life Sciences
Health Care

All
Solutions
People

Analysis

2020 Global Health Care Outlook

Laying a foundation for the future

Analysis

2020 Global life sciences outlook

Creating new value | Building blocks for the future

Gene therapies, intelligent drug discovery and development, consumer wearables, telemedicine, and more—what are some of the drivers transforming the life sciences sector? How can biopharma and medtech organizations create new value in 2020, while tackling various challenges?

Deloitte Insights

A consumer-centered future of health

Deloitte’s 2019 global health care consumer survey finds evidence that the future is now

Perspectives

The future of health

How innovation will blur traditional health care boundaries

The traditional boundaries of the life sciences and health care industry are dissolving as exponential innovation propels the future of health forward.

Article

Ten years on

Measuring the return from pharmaceutical innovation 2019

Deloitte Insights

Intelligent biopharma

Forging the links across the value chain

Deloitte Insights

Winning in the future of medtech

How consumer tech partnerships can lead to success in a transforming industry

Medtech companies are well-positioned to drive the future of health, but most cannot do it alone. They should instead partner with consumer technology and specialized digital health companies to meet the changing market.

Article

Going beyond compliance to achieve
radical interoperability

Pulse survey on CMS and ONC proposed rules

Article

2019 Global Impact Report

Connect for impact

Deloitte Insights

Maintaining value in pharmaceutical compliance

How can companies modernize programs through digital to deliver strategic value?

Deloitte Insights

Tackling digital transformation in life sciences

How biopharma companies can realize the power of digital and prepare for a new reality

Deloitte Insights

Return on capital performance in life sciences and health care

How have organizations performed and where are best bets going forward?

Perspectives

Digital transformation in life sciences

How pharma and medtech can shift from doing digital to being digital

Deloitte Insights

Smart health communities and the future of health

Five core components industry and government stakeholders can consider in the shift to health and well-being

Deloitte Insights

The health plan of tomorrow

Business model transformation is the only way to adapt to disruption

Deloitte Insights

Forces of change in health care

The future of health

The future of health will likely be driven by digital transformation enabled by radically interoperable data and open, secure platforms.

Deloitte Insights

Showing cybersecurity's value to health care leadership

Seven strategies for life sciences and health care organizations

Perspectives

Enabling smart health care with a modern analytics architecture

Tackling the global challenge of non-communicable diseases

Events

FT Global Pharma & Biotechnology Conference 2019

This industry-leading event joins life sciences companies and their health care sector counterparts to review trends and opportunities for creating a successful life sciences economy. The event also features discussions of strategies to help companies thrive in an era of unparalleled disruption.

Article

Platforms and Ecosystems

Enabling the Digital Economy

This whitepaper, part of the World Economic Forum's "Shaping the Future of the Digital Economy and Society initiative," looks at six key dimensions that determine whether digital platforms can retain public trust and governance and how they can revamp public-private collaboration for the same.

Article

The future of Life Sciences and Health Care in Asia Pacific

Embrace, Build and Grow

Article

Embracing the future of work to unlock R&D productivity

Measuring the return from pharmaceutical innovation 2018

The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began in 2010. Can this trend be reversed?

Events

Financial Times US Pharma and Biotech Summit

Join us on 14 May 2019 at Convene - 605 Third Avenue, New York

Article

Medtech and the Internet of Medical Things

How connected medical devices are transforming health care

New research from Deloitte UK Centre for Health Solutions examines how the IoMT is transforming medtech’s role in health care. It outlines how medtech companies can get digital transformation right – whether through adapting their existing business models, inventing new ones or both.

Article

A bold future for life sciences regulation

Predictions 2025

A special look at how life sciences regulation is evolving from a barrier to an accelerator of innovation.

Perspectives

Video: Artificial intelligence in health care

Deloitte’s Dr. Matt Howard and Dr. Ronen Gordon give insights into how artificial intelligence engines are helping health care systems to address some productivity challenges by analyzing reams of unstructured data.

Perspectives

The digital hospital of the future

In 10 years, technology may change the face of global health care delivery

Learn how the digital hospital of the future can leverage technology to transform the future of health care delivery, including digital patient experience in this report developed by Deloitte US.

Deloitte Insights

How do health care consumers and doctors perceive virtual care?

Our 2018 survey results show an interesting juxtaposition

Virtual health care is popular—in theory. Deloitte surveys of US physicians and health care consumers found support for the concept, but doctors aren’t meeting demand. However, organizations that get on board sooner rather than later may see the benefits.

Deloitte Insights

Survey finds biopharma companies lag in digital transformation

It is time for a sea change in strategy

Here’s how companies can take an enterprisewide approach to digital transformation—including strategic changes to leadership and talent, as well as funding.

Article

Future of business interaction

A study on the interaction between MedTech companies and hospitals

With this study, we shine a spotlight on the challenges in business interactions today. We aim to drive forward the discussion among stakeholders so as to find solutions that can be applied broadly, yielding benefits for all parties involved.

Perspectives

A life sciences and health care perspective: Tech Trends 2018

Technology trends transforming the future of life sciences and health care

Deloitte Insights

The future of real-world evidence

A focus on end-to-end, AI-driven, internally developed solutions

Article

EU Clinical Trial Regulation

Building a successful program

The implementation of the new European Union (EU) Clinical Trial Regulation will provide a unified portal and database for trial sponsors and regulatory agencies across the EU Member States, promising to bring greater regulatory convergence and efficiency to the clinical trial application process.

Predictions

The future awakens

Life Sciences and Health Care Predictions 2022

The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models. These are some of our predictions that, if they come true, will shake up the life sciences and health care industry.

Deloitte Insights

Strategies for stemming the opioid epidemic

How analytics can aid health plans and PBMs

The opioid crisis in the United States continues to reverberate across society. While a holistic solution remains elusive, health plans and pharmacy benefit managers are evolving their use of data analytics and technology to improve prevention and treatment among their members and in their communities.

Article

Time to care

Securing a future for the hospital workforce in Europe

In light of rising demand, staff shortages and lack of time for hands-on-care, is the current hospital workforce model sustainable? New research released by the Deloitte UK Centre for Health Solutions explores the current state of hospital workforces across Europe and their key challenges.

Analysis

Pharma and the connected patient

How digital technology is enabling patient centricity

New research released by the Deloitte UK Centre for Health Solutions explores how digital technology can help pharma embrace patient centricity to remain relevant, profitable, and to deliver better health outcomes.

Perspectives

Join the conversation

Social media connections to Deloitte's LSHC practice

Article

The bigger picture

Impact of EU regulatory change on the global life sciences industry

Analysis

Top 10 health care innovations

More value, better outcomes, for less

Survey of health care leaders explores the top 10 health care innovations. What innovations may provide more value and transform the industry?

Contact us

Contact us via our online form

Services

Deloitte U.S. Center for Health Solutions

The health services research arm of Deloitte United States.
Deloitte UK Centre for Health Solutions

The health services research arm of Deloitte United Kingdom.
Life sciences supply chain

Helping to optimize, reinvent and improve supply chains for companies across the pharmaceutical, biotechnology and medical device industries. Read to learn more.
Global Salesforce Assets & Solutions Group

Harness the power of industry-specific extensions to the Salesforce platform designed to solve real issues and deliver tangible value.
Deloitte Analytics

Life Sciences and Healthcare Learn how Deloitte member firms are helping organizations link business strategy to advanced analytical techniques to improve decision-making capabilities.

Similar topics

Life Sciences and Health Care

Greg Reh

Deloitte Global Life Sciences & Health Care Leader

grreh@deloitte.com

+1 215 977 7559

Stephanie Allen

Global Public Health & Social Services Leader

steallen@deloitte.com.au

+61 02 9322 3118

What do you think?

Join the conversation on Twitter

Contact us
Submit RFP
Job search

Global Office Directory

Office Locations

Location: GLOBAL-EN GLOBAL-English

About Deloitte

Newsroom
Social media
Leadership blog
Press releases
Submit an RFP
Job Search
Global office directory
Contact us
About Deloitte's network

Services

Audit & Assurance
Consulting
Risk Advisory
Financial Advisory
Legal
Tax

Industries

Consumer
Energy, Resources & Industrials
Financial Services
Government & Public Services
Life Sciences & Health Care
Technology, Media & Telecommunications

Careers

Job search
Experienced hires
Students
Life at Deloitte
Alumni

About Deloitte
Terms of use
Cookies
Privacy
Privacy Shield
Accessibility statement

© 2020. For information, contact Deloitte Touche Tohmatsu Limited.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”), its global network of member firms, and their related entities. DTTL (also referred to as “Deloitte Global”) and each of its member firms are legally separate and independent entities. DTTL does not provide services to clients. Please see www.deloitte.com/about to learn more.